Forrester Research, Inc. (NASDAQ:FORR – Get Free Report) was the recipient of a significant decline in short interest during the month of October. As of October 31st, there was short interest totalling 321,400 shares, a decline of 10.9% from the October 15th total of 360,800 shares. Based on an average trading volume of 73,400 shares, the short-interest ratio is currently 4.4 days. Currently, 2.8% of the shares of the stock are short sold.
Analyst Ratings Changes
Separately, StockNews.com upgraded Forrester Research from a “hold” rating to a “buy” rating in a report on Tuesday, November 12th.
Read Our Latest Research Report on FORR
Institutional Trading of Forrester Research
Forrester Research Trading Down 3.8 %
Shares of NASDAQ:FORR traded down $0.63 during midday trading on Friday, hitting $16.09. 95,404 shares of the stock were exchanged, compared to its average volume of 77,120. The stock has a market capitalization of $305.71 million, a price-to-earnings ratio of -45.97, a P/E/G ratio of 1.30 and a beta of 0.88. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.91 and a current ratio of 0.98. The business’s 50-day moving average price is $16.62 and its 200 day moving average price is $17.55. Forrester Research has a 12 month low of $14.38 and a 12 month high of $27.89.
About Forrester Research
Forrester Research, Inc operates as an independent research and advisory company in the United States and internationally. The company operates in three segments: Research, Consulting, and Events. The Research segment primary subscription research services include Forrester Decisions, Forrester Research, and SiriusDecisions Research, which are designed to provide business and technology leaders with a proven path to growth through customer obsession.
Read More
- Five stocks we like better than Forrester Research
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Overbought Stocks Explained: Should You Trade Them?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Forrester Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forrester Research and related companies with MarketBeat.com's FREE daily email newsletter.